Valeant Pharmaceuticals International / Dow Pharmaceutical Sciences, Inc.
2009 · Acquisition/Merger · $285M · Complete
Announcement Sentiment
100
Strongly positive
Valeant Pharmaceuticals acquired Dow Pharmaceutical Sciences, a dermatology specialty firm, for ~$285M to strengthen its US dermatology franchise. Remove the 'Source:' clause and erroneous Mylan reference.